Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Change in Accounts Payable 2011-2025 | ZTS

Zoetis annual/quarterly change in accounts payable history and growth rate from 2011 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
  • Zoetis change in accounts payable for the quarter ending June 30, 2025 was $24M, a 20% increase year-over-year.
  • Zoetis change in accounts payable for the twelve months ending June 30, 2025 was $48M, a 128.57% increase year-over-year.
  • Zoetis annual change in accounts payable for 2024 was $0.031B, a 138.46% increase from 2023.
  • Zoetis annual change in accounts payable for 2023 was $0.013B, a 144.83% decline from 2022.
  • Zoetis annual change in accounts payable for 2022 was $-0.029B, a 70.59% increase from 2021.
  
Zoetis Annual Change in Accounts Payable
(Millions of US $)
2024 $31
2023 $13
2022 $-29
2021 $-17
2020 $147
2019 $-10
2018 $37
2017 $-10
2016 $-28
2015 $17
2014 $-210
2013 $-82
2012 $96
2011 $-16
2010 $25
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $68.857B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $71.053B 27.33
Takeda Pharmaceutical (TAK) Japan $47.283B 9.65
Daiichi Sankyo, - (DSNKY) Japan $45.957B 23.55
BeOne Medicines - (ONC) Switzerland $32.895B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.654B 0.00
Summit Therapeutics (SMMT) United States $18.426B 0.00
Merck (MKKGY) Germany $16.343B 10.63
Shionogi (SGIOY) Japan $14.666B 14.69
United Therapeutics (UTHR) United States $13.773B 11.92
Neurocrine Biosciences (NBIX) United States $13.700B 40.87
Orion OYJ (ORINY) Finland $11.244B 27.10
IPSEN (IPSEY) France $11.184B 0.00
Madrigal Pharmaceuticals (MDGL) United States $9.438B 0.00
Eisai (ESAIY) $9.099B 10.26
Corcept Therapeutics (CORT) United States $7.348B 61.71
Ionis Pharmaceuticals (IONS) United States $6.814B 0.00
Stevanato Group S.p.A (STVN) Italy $6.784B 40.00
Grifols, S.A (GRFS) Spain $6.738B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.597B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.940B 13.97
Crinetics Pharmaceuticals (CRNX) United States $2.863B 0.00
Hypermarcas (HYPMY) Brazil $2.831B 21.29
Procaps Group, S.A (PROCF) Luxembourg $2.799B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.756B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.471B 8.27
Centessa Pharmaceuticals (CNTA) United Kingdom $2.230B 0.00
Ocular Therapeutix (OCUL) United States $2.144B 0.00
Dyne Therapeutics (DYN) United States $1.940B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
Guardian Pharmacy Services (GRDN) United States $1.631B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.594B 23.75
Ardelyx (ARDX) United States $1.492B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.444B 0.00
Harrow (HROW) United States $1.435B 0.00
ARS Pharmaceuticals (SPRY) United States $1.328B 0.00
Xeris Biopharma Holdings (XERS) United States $1.290B 0.00
Evotec AG (EVO) Germany $1.239B 0.00
Enliven Therapeutics (ELVN) United States $1.225B 0.00
Collegium Pharmaceutical (COLL) United States $1.222B 6.68
Cronos Group (CRON) Canada $0.981B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.843B 0.00
Akebia Therapeutics (AKBA) United States $0.798B 0.00
ProKidney (PROK) United States $0.733B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.713B 7.34
Theravance Biopharma (TBPH) United States $0.695B 57.50
KalVista Pharmaceuticals (KALV) United States $0.684B 0.00
Bioventus (BVS) United States $0.619B 14.98
Relay Therapeutics (RLAY) United States $0.616B 0.00
Organogenesis (ORGO) United States $0.614B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
Tourmaline Bio (TRML) United States $0.604B 0.00
Siga Technologies (SIGA) United States $0.591B 7.30
USANA Health Sciences (USNA) United States $0.587B 12.03
Xencor (XNCR) United States $0.572B 0.00
Savara (SVRA) United States $0.569B 0.00
Oruka Therapeutics (ORKA) United States $0.569B 0.00
Nektar Therapeutics (NKTR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.525B 0.00
Esperion Therapeutics (ESPR) United States $0.440B 0.00
Nanobiotix S.A (NBTX) France $0.431B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.350B 0.00
Altimmune (ALT) United States $0.324B 0.00
Larimar Therapeutics (LRMR) United States $0.323B 0.00
4D Molecular Therapeutics (FDMT) United States $0.302B 0.00
Nature's Sunshine Products (NATR) United States $0.298B 19.40
AleAnna (ANNA) United States $0.283B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.282B 0.00
Lexeo Therapeutics (LXEO) United States $0.262B 0.00
Galectin Therapeutics (GALT) United States $0.255B 0.00
Lyell Immunopharma (LYEL) United States $0.217B 0.00
Heron Therapeutics (HRTX) United States $0.208B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.205B 31.50
Korro Bio (KRRO) United States $0.203B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.197B 0.00
MediWound (MDWD) Israel $0.184B 0.00
Journey Medical (DERM) United States $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.172B 0.00
MEI Pharma (MEIP) United States $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.133B 0.00
Wellgistics Health (WGRX) United States $0.130B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 20.62
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Liminatus Pharma (LIMN) United States $0.079B 0.00
Context Therapeutics (CNTX) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Prelude Therapeutics (PRLD) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Karyopharm Therapeutics (KPTI) United States $0.068B 0.00
Gain Therapeutics (GANX) United States $0.067B 0.00
Inotiv (NOTV) United States $0.060B 0.00
DURECT (DRRX) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Rafael Holdings (RFL) United States $0.053B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.91
Fractyl Health (GUTS) United States $0.050B 0.00
Plus Therapeutics (PSTV) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Tempest Therapeutics (TPST) United States $0.048B 0.00
Klotho Neurosciences (KLTO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.043B 0.00
FibroGen (FGEN) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.021B 0.00
Incannex Healthcare (IXHL) Australia $0.020B 0.00
Ainos (AIMD) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
ESSA Pharma (EPIX) Canada $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Vyome Holdings (HIND) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.69
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00